BON NATURAL LIFE LIMITED (BON) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.04%; Formula and calculation Research and development expense / revenue. Period ending 2025-09-30..
- Stock-based compensation / revenue · 12 months: Value 7.46%; Formula and calculation Share-based compensation / revenue. Period ending 2025-09-30..
- Interest coverage · 12 months: Value -4.43×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.04% | Research and development expense / revenue. Period ending 2025-09-30. $754.19K ÷ $18.67M × 100 ≈ 4.04% |
| Stock-based compensation / revenue · 12 months | 7.46% | Share-based compensation / revenue. Period ending 2025-09-30. $1.39M ÷ $18.67M × 100 ≈ 7.46% |
| Interest coverage · 12 months | -4.43× | Operating income ÷ reported interest expense. $-1.62M ÷ $366.18K ≈ -4.43× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 754.19K USD | Research and Development Expense |
| Revenue | 18.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.39M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -1.62M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 366.18K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $754.19K | $18.67M | $1.39M | $-1.62M | $366.18K | 4.04% | 7.46% | -4.43× | Reported |
| 2024-09-30 | $1.62M | $23.84M | $1.32M | $1.87M | $303.32K | 6.80% | 5.54% | 6.18× | Reported |
| 2023-09-30 | $298.47K | $29.52M | $218.30K | $5.92M | $238.22K | 1.01% | 0.74% | 24.84× | Reported |
| 2022-09-30 | $424.56K | $29.91M | (m) | $6.54M | $446.88K | 1.42% | (m) | 14.64× | Reported |
| 2022-03-31 | $306.73K | $27.48M | (m) | $5.65M | $497.86K | 1.12% | (m) | 11.36× | Reported |
| 2021-09-30 | $249.05K | $25.49M | $422.22K | $5.40M | $417.27K | 0.98% | 1.66% | 12.94× | Reported |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $205.36K | $18.22M | $211.11K | $3.47M | $329.10K | 1.13% | 1.16% | 10.54× | Reported |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $522.87K | $16.40M | (m) | $3.18M | $333.19K | 3.19% | (m) | 9.53× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.